Biofrontera Inc.
BFRI
$1.08
-$0.02-1.82%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -10.54M | -17.57M | -16.59M | -11.53M | -17.76M |
| Total Depreciation and Amortization | 868.00K | 869.00K | 974.00K | 1.06M | 1.15M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -209.00K | 619.00K | 960.00K | -4.30M | 128.00K |
| Change in Net Operating Assets | -3.48M | 4.08M | 5.27M | 3.70M | 6.21M |
| Cash from Operations | -13.36M | -12.00M | -9.39M | -11.06M | -10.27M |
| Capital Expenditure | -2.00K | -4.00K | -5.00K | 44.00K | -10.00K |
| Sale of Property, Plant, and Equipment | 3.00M | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 0.00 | 0.00 | -50.00K | 7.00K |
| Cash from Investing | 3.00M | -4.00K | -5.00K | -6.00K | -3.00K |
| Total Debt Issued | -- | 4.05M | 4.05M | 4.05M | 4.05M |
| Total Debt Repaid | -- | 0.00 | -298.00K | -2.45M | -4.32M |
| Issuance of Common Stock | -- | 0.00 | 0.00 | 0.00 | 7.66M |
| Repurchase of Common Stock | -- | -- | -- | -224.00K | -224.00K |
| Issuance of Preferred Stock | 10.85M | 8.50M | 0.00 | 7.66M | 7.66M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | 8.50M | -- | -- |
| Cash from Financing | 10.85M | 12.55M | 12.25M | 9.04M | 14.84M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 487.00K | 544.00K | 2.86M | -2.03M | 4.56M |